Dr. Reddy’s Laboratories Limited RDY on Friday launched its generic Semaglutide Injection in Canada. This move is significant as it positions Dr. Reddy’s among the first companies to introduce this ...
Indian pharma major Dr Reddy's Laboratories has received regulatory approval from Health Canada to sell the first generic version of Novo Nordisk's blockbuster diabetes-cum-weight-loss drug Ozempic ...
Dr. Reddy's Laboratories Limited RDY reported third-quarter fiscal 2025 earnings of 20 cents per American Depositary Share (ADS), which matched the Zacks Consensus Estimate. The company reported ...
Dr. Reddy’s Laboratories RDY is a major player in the generic drugs markets. The company reports its financial performance under three operating segments — Global Generics, Pharmaceutical Services & ...
Dr. Reddy’s becomes the first company to receive marketing authorization for generic Semaglutide Injection in Canada The market authorization was granted to Dr. Reddy’s ahead of Health Canada’s review ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results